Ventas, Inc. $VTR Shares Sold by Prestige Wealth Management Group LLC

Prestige Wealth Management Group LLC reduced its stake in Ventas, Inc. (NYSE:VTRFree Report) by 93.9% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 410 shares of the real estate investment trust’s stock after selling 6,296 shares during the period. Prestige Wealth Management Group LLC’s holdings in Ventas were worth $32,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of VTR. NewEdge Advisors LLC raised its holdings in Ventas by 856.1% in the 1st quarter. NewEdge Advisors LLC now owns 7,926 shares of the real estate investment trust’s stock valued at $545,000 after buying an additional 7,097 shares during the period. Empowered Funds LLC raised its holdings in Ventas by 6.8% in the 1st quarter. Empowered Funds LLC now owns 8,373 shares of the real estate investment trust’s stock valued at $576,000 after buying an additional 536 shares during the period. Woodline Partners LP raised its holdings in Ventas by 46.8% in the 1st quarter. Woodline Partners LP now owns 36,826 shares of the real estate investment trust’s stock valued at $2,532,000 after buying an additional 11,739 shares during the period. Focus Partners Wealth raised its holdings in Ventas by 130.4% in the 1st quarter. Focus Partners Wealth now owns 21,613 shares of the real estate investment trust’s stock valued at $1,486,000 after buying an additional 12,233 shares during the period. Finally, Gamco Investors INC. ET AL purchased a new stake in Ventas in the 2nd quarter valued at about $805,000. 94.18% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of analysts have issued reports on VTR shares. Wells Fargo & Company boosted their price target on shares of Ventas from $93.00 to $96.00 and gave the stock an “overweight” rating in a research note on Monday, June 1st. Morgan Stanley set a $90.00 price target on shares of Ventas in a research note on Friday, February 13th. Weiss Ratings reiterated a “buy (b-)” rating on shares of Ventas in a research note on Friday, March 27th. JPMorgan Chase & Co. boosted their price target on shares of Ventas from $93.00 to $94.00 and gave the stock an “overweight” rating in a research note on Monday, May 11th. Finally, The Goldman Sachs Group reiterated a “buy” rating and set a $110.00 price target on shares of Ventas in a research note on Tuesday, May 19th. Fourteen analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $95.19.

Check Out Our Latest Stock Analysis on Ventas

Insider Activity at Ventas

In related news, Director Michael J. Embler purchased 2,500 shares of the company’s stock in a transaction on Wednesday, June 3rd. The shares were bought at an average cost of $78.81 per share, for a total transaction of $197,025.00. Following the completion of the purchase, the director directly owned 19,202 shares of the company’s stock, valued at approximately $1,513,309.62. This trade represents a 14.97% increase in their position. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Walter C. Rakowich sold 1,152 shares of the stock in a transaction that occurred on Thursday, May 14th. The shares were sold at an average price of $90.20, for a total transaction of $103,910.40. Following the completion of the transaction, the director owned 28,349 shares in the company, valued at $2,557,079.80. This represents a 3.90% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 0.53% of the company’s stock.

Ventas Stock Performance

Shares of Ventas stock opened at $82.13 on Friday. The firm has a market capitalization of $39.93 billion, a P/E ratio of 149.33, a P/E/G ratio of 1.75 and a beta of 0.71. Ventas, Inc. has a 52 week low of $61.76 and a 52 week high of $91.06. The company has a quick ratio of 0.25, a current ratio of 0.25 and a debt-to-equity ratio of 0.95. The firm’s 50 day moving average is $85.05 and its two-hundred day moving average is $82.36.

Ventas (NYSE:VTRGet Free Report) last announced its quarterly earnings results on Monday, April 27th. The real estate investment trust reported $0.11 EPS for the quarter, missing the consensus estimate of $0.12 by ($0.01). The company had revenue of $1.65 billion during the quarter, compared to analysts’ expectations of $1.59 billion. Ventas had a net margin of 4.25% and a return on equity of 2.09%. The business’s revenue for the quarter was up 22.0% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.84 earnings per share. Ventas has set its FY 2026 guidance at 3.820-3.890 EPS. Research analysts forecast that Ventas, Inc. will post 3.88 EPS for the current fiscal year.

Ventas Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, July 16th. Shareholders of record on Tuesday, June 30th will be paid a $0.52 dividend. This represents a $2.08 annualized dividend and a yield of 2.5%. The ex-dividend date is Tuesday, June 30th. Ventas’s dividend payout ratio is currently 378.18%.

Ventas Company Profile

(Free Report)

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.

See Also

Want to see what other hedge funds are holding VTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ventas, Inc. (NYSE:VTRFree Report).

Institutional Ownership by Quarter for Ventas (NYSE:VTR)

Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.